6 completed. 6 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 6 |
| Phase 1 | 1 | Completed 1 |
Follow Yellow Fever: new trials by email Literature Review of Yellow Fever trials Research Report on Yellow Fever
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Modulate Cellular Stress in the Immune Cells to Reduce Rate of Symptomatic Viral Infection Metformin Hydrochloride, Calcium and Vitamin D - Endoplasmic Reticulum Stress, Viral Infection | Phase 2 | Completed | Singapore General Hospital | 32 | 2021-10-22 | 2024-04-17 |
| The Effect of Inflammation and Damage to Lymph Node Structures on Durable Protective Immunity Following Yellow Fever Vaccination Yellow Fever Vaccine - Yellow Fever | Phase 1 / Phase 2 | Completed | University of Minnesota | 43 | 2020-07-01 | 2025-10-07 |
| Yellow Fever Vaccine on Statin/ Non Statin Subjects Stamaril (live attenuated yellow fever vaccine) - Yellow Fever Vaccine, Yellow Fever | Phase 2 | Completed | Singapore General Hospital | 37 | 2017-03-08 | 2020-03-23 |
| The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in Humans Japanese Encephalitis vaccine, Yellow Fever vaccine - Yellow Fever, Encephalitis, Japanese | Phase 2 | Completed | Singapore General Hospital | 84 | 2013-10-01 | 2016-04-20 |
| Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever Vaccine Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virus, Yellow Fever - Dengue, Dengue Fever | Phase 2 | Completed | Sanofi Pasteur, a Sanofi Company | 390 | 2011-12-06 | 2022-03-24 |
| Study of Live Attenuated Japanese Encephalitis Vaccine (ChimeriVax™-JE) and Yellow Fever Vaccine (STAMARIL®) Live attenuated Japanese encephalitis virus; Yellow fever virus, Yellow fever virus; Live attenuated Japanese encephalitis virus - Japanese Encephalitis, Yellow Fever | Phase 2 | Completed | Sanofi | 108 | 2004-07-01 | 2012-09-20 |
Encephalitis, Japanese (2) · Dengue (1) · Severe Dengue (1) · Virus Diseases (1)
Arbovirus Infections (6) · Flaviviridae Infections (6) · Flavivirus Infections (6) · Hemorrhagic Fevers, Viral (6) · Infections (6) · Mosquito-Borne Diseases (6) · RNA Virus Infections (6) · Vector Borne Diseases (6) · Virus Diseases (5) · Brain Diseases (2) · Central Nervous System Diseases (2) · Central Nervous System Infections (2) · Central Nervous System Viral Diseases (2) · Encephalitis (2) · Encephalitis, Arbovirus (2)
Yellow Fever Vaccine (3) · Calcium (1) · Japanese Encephalitis Vaccines (1) · Metformin (1) · Vitamin D (1)
Singapore General Hospital (3) · Sanofi (1) · Sanofi Pasteur, a Sanofi Company (1) · University of Minnesota (1)
Singapore (3) · United States (2) · Australia (1) · Uganda (1)
Jenny Dr Low (1) · Jenny GH Low, MRCP (UK) (1) · Jenny Low Guek Hong (1) · Timothy Schacker, MD (1)
PMID 20864814, PMID 25872531, PMID 30241510
U01AI141981 (1)